Publications

Investigation of Debio 025, a cyclophilin inhibitor, in the dystrophic mdx mouse, a model for Duchenne muscular dystrophy

Inhibition of Human Immunodeficiency Virus Type 1 Replication in Human Cells by Debio-025, a Novel Cyclophilin Binding Agent

Hexokinase II Detachment from Mitochondria triggers Apoptosis through the Permeability Transition Pore Independent of Voltage-Dependent Anion Channels

Genetic and Pharmacologic Inhibition of Mitochondrial-dependent Necrosis Attenuates Muscular Dystrophy

The Cyclophilin Inhibitor Debio-025 Shows Potent Anti-Hepatitis C Effect in Patients Coinfected with Hepatitis C and Human Immunodeficiency Virus

The Role of Cyclophilins and Cyclophilin Inhibitors in the Replication of HCV

The cyclophilin inhibitor Debio 025 is a potent inhibitor of Hepatitis C virus replication in vitro and has unique resistance…

Cyclophilin inhibitors in Hepatitis C viral Infection

Inhibition of mitochondrial permeability transition improves functional recovery and reduces mortality following acute myocardial infarction in mice